
Article
11/02/2025
CMED calls for contributions on pricing regulation of advanced therapy products
On Friday, February 7th, the Pharmaceutical Market Regulation Chamber (CMED) published in the Federal Register the Notice of Call #1/2025, which aims to collect data, information, opinions and suggestions from society on the criteria that should be established in the pricing of advanced therapy products. Such information will support the preparation of the Regulatory Impact Analysis …








